Latest News & Features
Asia
Indian pharmaceutical company Intas Pharmaceuticals has been granted an injunction preventing a rival from marketing an anti-epilepsy drug it said infringed one of its trademarks. 30 October 2014
Asia
A recent decision from the IPAB on the patent eligibility of biological processes could change the biotech playing field in India, say Swarup Kumar and Shivaarti Bajaj. 29 October 2014
Biotechnology
Should it be possible for a drug maker to stop the owner of a patented ingredient from obtaining an SPC? Ashley Roughton examines the CJEU’s opinion on Eli Lilly v HGS. 29 October 2014
Americas
In the competitive world of cancer treatment it’s becoming ever more important to stand out from the crowd. LSIPR speaks to TapImmune’s chief executive Glynn Wilson on why he thinks the company does. 29 October 2014
Americas
A US court has ruled that pharmaceutical company Mylan infringed a patent owned by The Medicines Company covering a product used to inhibit blood clots. 29 October 2014
Big Pharma
Pharmaceutical company Bristol-Myers Squibb has agreed a deal that gives it the option of acquiring drug maker F-star Alpha and one of its breast and gastric cancer treatments. 28 October 2014
Americas
Pharmaceutical company AstraZeneca has filed a patent infringement lawsuit against drug maker Pharmadax after it applied to market a generic version of a schizophrenia and bipolar disorder treatment. 27 October 2014
Generics
A US court has rejected attempts by two companies to market generic versions of a birth control pill owned by pharmaceutical company Actavis. 24 October 2014
Generics
The South African government has been urged to act quickly and honour its plans to overhaul its patent laws, which some have claimed could lead to an increase in affordable generic medicines. 23 October 2014